About Nanomedic

Nanomedic Technologies Ltd. is an Israeli bio-medical therapeutics high-technology company specializing in clinical research, and distribution of medical devices based on electrospinning technology. It is focused on the development of Electrospun Healing Fibers (EHF™) with its ultimate goal being embedded cells for tissue regeneration. This is the future of advanced wound care solutions that will fill the void of personalized medicine while endeavoring to cure and heal patients rather than ameliorating symptoms.

We have already started marketing and sales of its wound healing Spincare system to selected global healthcare institutions, with a market potential of over $18B. Nanomedic’s Spincare patented platform technology, together with its disposable ampule, has wide market applications both within and outside the hospital environs. It is CE marked and FDA clearance is expected in mid-2021.

Leveraging electrospinning technology, Nanomedic has developed the world’s first commercialized handheld device that enables healthcare professionals to print – in real-time – a nanofibrous healing matrix directly onto a patient’s wound. The Spincare wound healing System is a total paradigm shift in the treatment of wounds from superficial to hard-to-heal chronic and complex wounds.

Nanomedic is committed to advancing the standard of care and helping improve wound healing across the healthcare continuum.

Leadership

CEO

Dr. Chen Barak

Dr. Barak has more than 20 years of proven experience in the development and commercialization of medical devices. She has held multiple managerial positions in the medical device industry at Florence Medical Ltd. and FlowMedic Ltd. Prior to joining Nanomedic, Chen served as the General Manager of Gardia Medical for more than 6 years. Dr. Barak graduated from the Technion Institute in Haifa, Israel and received her Ph.D. in Biomedical Engineering at UT Southwestern, Dallas, TX.
CFO

Guy Harel

A Certified Public Accountant and an Attorney at Law in Israel. Guy served as CFO of WhiteSmoke Software Ltd., a publicly traded Software company and as a business controller at Microsoft Israel R&D center. Guy also worked as a capital markets and high tech team member at FBC&Co, one of Israel’s leading law firms, and as an audit team manager at Ernst & Young Israel. Guy is a Bachelor of Laws and also holds a B.A in Accounting, both from Tel Aviv university.
CTO

Dr. Claudia M. Barzilay

Dr. Barzilay has over 15 years of recognized research and development experience in the field of Pharma, Biotech and Medical Devices. Prior to joining Nanomedic, Claudia served as Project Manager, Scientific Advisory and VP R&D, gaining vast knowledge in Product Development, GLP Regulations, Patent writing and Business Development. She received her Ph.D. in Chemistry from the Technion- Israel Institute of Technology, pursued postdoctoral research at Stanford University, CA- USA and achieved a Researcher and Lecturer position at the Hebrew University.
VP Marketing & Sales

Dr. Gary J. Sagiv

Dr. Sagiv brings nearly twenty-year track record of building and leading successful business programs for global diagnostic and biotechnology start-up companies. With a diverse and rich background in worldwide activities in the Medical Devices segment, Gary adds a broad base of commercialization expertise from responsibilities in marketing research, business development, marketing & sales and general management. In his senior management positions, he has initiated programs of international growth for the company, encompassing both pre and commercial sales; built and lead commercial teams globally and has conducted business in over 70 countries.
VP Operations

Daniel Sclar

Mr. Sclar brings over 25 years of management experience to Nanomedic. He served as an operations and logistics manager in the IDF and has held executive positions in the nanotech and medical device industries.
Prior to joining Nanomedic, Sclar served as ECO of NonoMaterials Ltd, and VP OP's of CathWorks, Angioslide, DNR BioImaging and others.
He has a M.Sc. in Industrial Engineering from the Technion- Israel Institute of Technology and MBA from Ben Gurion University in Beer Sheva, Israel
VP QA/RA

Asher Zilberstein

Mr. Zilberstein has more than 20 years of experience in establishment and management of quality, and regulation assurance activities in the medical device industry, from the development stage to post marketing environments.
Prior to joining Nanomedic, Asher served as QA/RA leader of Endospan, Valtech Medical (Edwards), West Micro infusion Design Center, Gardia Medical, and others.
He has a M.Sc. in Biotechnology from the School of Medicine at the Hebrew University in Jerusalem, Israel.
CEO

Dr. Chen Barak

Dr. Barak has more than 20 years of proven experience in the development and commercialization of medical devices. She has held multiple managerial positions in the medical device industry at Florence Medical Ltd. and FlowMedic Ltd. Prior to joining Nanomedic, Chen served as the General Manager of Gardia Medical for more than 6 years. Dr. Barak graduated from the Technion Institute in Haifa, Israel and received her Ph.D. in Biomedical Engineering at UT Southwestern, Dallas, TX.
CFO

Guy Harel

A Certified Public Accountant and an Attorney at Law in Israel. Guy served as CFO of WhiteSmoke Software Ltd., a publicly traded Software company and as a business controller at Microsoft Israel R&D center. Guy also worked as a capital markets and high tech team member at FBC&Co, one of Israel’s leading law firms, and as an audit team manager at Ernst & Young Israel. Guy is a Bachelor of Laws and also holds a B.A in Accounting, both from Tel Aviv university.
CTO

Dr. Claudia M. Barzilay

Dr. Barzilay has over 15 years of recognized research and development experience in the field of Pharma, Biotech and Medical Devices. Prior to joining Nanomedic, Claudia served as Project Manager, Scientific Advisory and VP R&D, gaining vast knowledge in Product Development, GLP Regulations, Patent writing and Business Development. She received her Ph.D. in Chemistry from the Technion- Israel Institute of Technology, pursued postdoctoral research at Stanford University, CA- USA and achieved a Researcher and Lecturer position at the Hebrew University.
VP Marketing & Sales

Dr. Gary J. Sagiv

Dr. Sagiv brings nearly twenty-year track record of building and leading successful business programs for global diagnostic and biotechnology start-up companies. With a diverse and rich background in worldwide activities in the Medical Devices segment, Gary adds a broad base of commercialization expertise from responsibilities in marketing research, business development, marketing & sales and general management. In his senior management positions, he has initiated programs of international growth for the company, encompassing both pre and commercial sales; built and lead commercial teams globally and has conducted business in over 70 countries.

Board of Directors

Active Chairman

Chen Katz

CEO of TechnoPlus Venture, a diversified public investment company, traded on the Tel-Aviv Stock Exchange (TASE: TNPV) since 1999. Mr. Chen Katz Possesses extensive experience in managing investments in companies and ventures of all maturity levels.
Director

John R. Harper, Ph.D

With more than 35 years' of experience, Dr. Harper currently serves as a Senior Medical Scientist in the Medical Solutions Division of 3M Health Care, where he is responsible for early-stage discovery and innovation related to advanced wound care. Dr. Harper previously served as Chief Technology Officer for 3M affiliate KCI, where he was responsible for innovation and technology development at the company's Center for Advanced Research and Technology. He also served as Vice President of Clinical Development and Clinical Sciences at biotechnology company LifeCell Corporation. Dr. Harper earned his Ph.D. in Biochemistry from the University of Texas Graduate School of Biomedical Sciences and M.D. Anderson Cancer Center.
Director

Erez Rozenfeld

Mr. Rozenfeld has a proven track record in global business development in the field of medical devices. He has overseen mergers and acquisitions. Mr. Rozenfeld had managerial positions in Lumenis UK, Aesthera Inc., RapiX and V-Wave as well as publicly traded companies as Teva Group and Agis.
Director

Ora Meir Soffer

Entrepreneur, CEO, Investor, Director and Advisory Board Member with 30 years of experience in capital raising, financing, M&A and IPO. Co-founder and partner of Citrine Technologies investment funds and partner of Mazu Ventures health-tech & wellness global fund.
Director

Hezy Aspis

Mr. Aspis has more than 25 years of experience in engineering and management of electronic and medical device industries.
Director

Zvi Yemini

A serial entrepreneur, has over 35 years of experience in the plastics industry as management and investor. He currently serves as Chairman of Shenkar College of Design.
Director

Gideon Petrover

Partner in Om-Maya, a private equity firm. Management experience in multinational corporation, focus in management and operations, information management.
Active Chairman

Chen Katz

CEO of TechnoPlus Venture, a diversified public investment company, traded on the Tel-Aviv Stock Exchange (TASE: TNPV) since 1999. Mr. Chen Katz Possesses extensive experience in managing investments in companies and ventures of all maturity levels.
Director

John R. Harper, Ph.D

With more than 35 years' of experience, Dr. Harper currently serves as a Senior Medical Scientist in the Medical Solutions Division of 3M Health Care, where he is responsible for early-stage discovery and innovation related to advanced wound care. Dr. Harper previously served as Chief Technology Officer for 3M affiliate KCI, where he was responsible for innovation and technology development at the company's Center for Advanced Research and Technology. He also served as Vice President of Clinical Development and Clinical Sciences at biotechnology company LifeCell Corporation. Dr. Harper earned his Ph.D. in Biochemistry from the University of Texas Graduate School of Biomedical Sciences and M.D. Anderson Cancer Center.
Director

Erez Rozenfeld

Mr. Rozenfeld has a proven track record in global business development in the field of medical devices. He has overseen mergers and acquisitions. Mr. Rozenfeld had managerial positions in Lumenis UK, Aesthera Inc., RapiX and V-Wave as well as publicly traded companies as Teva Group and Agis.
Director

Ora Meir Soffer

Entrepreneur, CEO, Investor, Director and Advisory Board Member with 30 years of experience in capital raising, financing, M&A and IPO. Co-founder and partner of Citrine Technologies investment funds and partner of Mazu Ventures health-tech & wellness global fund.
Director

Zvi Yemini

A serial entrepreneur, has over 35 years of experience in the plastics industry as management and investor. He currently serves as Chairman of Shenkar College of Design.
Director

Hezy Aspis

Mr. Aspis has more than 25 years of experience in engineering and management of electronic and medical device industries.
Director

Gideon Petrover

Partner in Om-Maya, a private equity firm. Management experience in multinational corporation, focus in management and operations, information management.

Scientific Board

Board Member

Professor Josef Haik, M.D; MPH

Prof. Dr. Josef Haik (born 1966, Ramat Gan, Israel) is a specialist in Aesthetic & Reconstruction Plastic Surgery and Burns. Prof Haik is the director of the National Intensive Care Burn Unit and Director of the Division of Plastic & Reconstructive at the Sheba Medical Center, Tel Hashomer Hospital, Ramat Gan Israel, affiliated to the Tel Aviv University. Prof. Haik is a Professor in the Faculty of Surgery at Tel Aviv University. Prof Haik completed his medical studies in 1994 at the University of Bologna, Italy and is a specialist in plastic surgery since 2002. Prof Haik completed felowship in Plastic Surgery in Sao Paulo, Brazil and in the ICU, Burns in the Hospital of the University of Alberta, Canada. Prof. Haik has a Master Degree in Public Health (MPH), Disasters management since 2008. Prof Haik is a member and chairman of the American Burn Association. He is a member in the Israeli Association for Aesthetic plastic surgery, the Israel Medical Association, the International Association for Aesthetic Surgery and the Israeli Association for healing wounds. Prof. Haik contributed to chapters in medical textbooks and published numerous articles.
Director

Mark Darty

Mark Darty has over 30 years’ experience, more than half of which is in medical devices. He held board, senior executive, and key management positions at cutting-edge companies in the medical device, consumer electronics, and aerospace markets including HyperMed Imaging, Luminetx, Brother International, Boeing/McDonnell Douglas, and General Dynamics. Most recently, he was Board Member, CEO, and President of HyperMed Imaging where he led the company from inception to global commercialization of its award-winning medical device for wound care and surgical applications. He has a B.S. in Electrical Engineering and an M.S. in Engineering with over 30 patents.
Director

Professor Jan Plock, M.D.

Prof. Plock currently serves as Chief of Plastic Surgery and Hand Surgery at the Aarau Canton Hospital (KSA), the largest hospital in the Aargau region, and one of the three largest hospital centers in Switzerland. He previously served in multiple roles at University Hospital Zurich, including Director of the Burn Center, Director of the Reconstructive Transplantation Program, and Director of the Post-Bariatric Body-Contouring Program. He was made a Fellow of the European Board of Plastic Surgeons in 2009 and earned his Adjunct Professorship from the University of Zurich in 2020.
Board Member

Professor Josef Haik, M.D; MPH

Prof. Dr. Josef Haik (born 1966, Ramat Gan, Israel) is a specialist in Aesthetic & Reconstruction Plastic Surgery and Burns. Prof Haik is the director of the National Intensive Care Burn Unit and Director of the Division of Plastic & Reconstructive at the Sheba Medical Center, Tel Hashomer Hospital, Ramat Gan Israel, affiliated to the Tel Aviv University. Prof. Haik is a Professor in the Faculty of Surgery at Tel Aviv University. Prof Haik completed his medical studies in 1994 at the University of Bologna, Italy and is a specialist in plastic surgery since 2002. Prof Haik completed felowship in Plastic Surgery in Sao Paulo, Brazil and in the ICU, Burns in the Hospital of the University of Alberta, Canada. Prof. Haik has a Master Degree in Public Health (MPH), Disasters management since 2008. Prof Haik is a member and chairman of the American Burn Association. He is a member in the Israeli Association for Aesthetic plastic surgery, the Israel Medical Association, the International Association for Aesthetic Surgery and the Israeli Association for healing wounds. Prof. Haik contributed to chapters in medical textbooks and published numerous articles.
Director

Mark Darty

Mark Darty has over 30 years’ experience, more than half of which is in medical devices. He held board, senior executive, and key management positions at cutting-edge companies in the medical device, consumer electronics, and aerospace markets including HyperMed Imaging, Luminetx, Brother International, Boeing/McDonnell Douglas, and General Dynamics. Most recently, he was Board Member, CEO, and President of HyperMed Imaging where he led the company from inception to global commercialization of its award-winning medical device for wound care and surgical applications. He has a B.S. in Electrical Engineering and an M.S. in Engineering with over 30 patents.
Director

Professor Jan Plock, M.D.

Prof. Plock currently serves as Chief of Plastic Surgery and Hand Surgery at the Aarau Canton Hospital (KSA), the largest hospital in the Aargau region, and one of the three largest hospital centers in Switzerland. He previously served in multiple roles at University Hospital Zurich, including Director of the Burn Center, Director of the Reconstructive Transplantation Program, and Director of the Post-Bariatric Body-Contouring Program. He was made a Fellow of the European Board of Plastic Surgeons in 2009 and earned his Adjunct Professorship from the University of Zurich in 2020.

Join our team

Do you want to be part of our team?
Come work with us and change the world of wound care.

Apply now